Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)

OBJECTIVE: To determine whether once-daily esomeprazole 40 mg or 20 mg compared with placebo reduces the incidence of peptic ulcers over 26 weeks of treatment in patients taking low-dose acetylsalicylic acid (ASA) and who are at risk for ulcer development. DESIGN: Multinational, randomised, blinded,...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheiman, James M, Devereaux, P J, Herlitz, Johan, Katelaris, Peter H, Lanas, Angel, Veldhuyzen van Zanten, Sander, Nauclér, Emma, Svedberg, Lars-Erik
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088470/
https://www.ncbi.nlm.nih.gov/pubmed/21415072
http://dx.doi.org/10.1136/hrt.2010.217547

Ejemplares similares

Ejemplares similares